Pharmaceutical Pollution from Human Use and the Polluter Pays Principle
Open Access
- 1 July 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 16 (2) , 152-164
Abstract
Human consumption of pharmaceuticals often leads to environmental release of residues via urine and faeces, creating environmental and public health risks. Policy responses must consider the normative question how responsibilities for managing such risks, and costs and burdens associated with that management, should be distributed between actors. Recently, the Polluter Pays Principle (PPP) has been advanced as rationale for such distribution. While recognizing some advantages of PPP, we highlight important ethical and practical limitations with applying it in this context: PPP gives ambiguous and arbitrary guidance due to difficulties in identifying the salient polluter. Moreover, when PPP does identify responsible actors, these may be unable to avoid or mitigate their contribution to the pollution, only able to avoid/mitigate it at excessive cost to themselves or others, or excusably ignorant of contributing. These limitations motivate a hybrid framework where PPP, which emphasizes holding those causing large-scale problems accountable, is balanced by the Ability to Pay Principle (APP), which emphasizes efficiently managing such problems. In this framework, improving wastewater treatment and distributing associated financial costs across water consumers or taxpayers stand out as promising responses to pharmaceutical pollution from human use. However, sound policy depends on empirical considerations requiring further study.Keywords
Funding Information
- Swedish Research Council (2018-05771)
- Sweden’s Innovation Agency (2021-02699)
- UGOT Challenges Initiative of the University of Gothenburg
This publication has 31 references indexed in Scilit:
- Management Options for Reducing the Release of Antibiotics and Antibiotic Resistance Genes to the EnvironmentEnvironmental Health Perspectives, 2013
- Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?Environmental Health Perspectives, 2012
- Climate change and the duties of the disadvantaged: reply to CaneyCritical Review of International Social and Political Philosophy, 2011
- Climate change and the duties of the advantagedCritical Review of International Social and Political Philosophy, 2010
- International and supranational systems of environmental liability in Europe2008
- Collapse of a fish population after exposure to a synthetic estrogenProceedings of the National Academy of Sciences, 2007
- Diclofenac residues as the cause of vulture population decline in PakistanNature, 2004
- Historical Emissions and Free-RidingEthical Perspectives, 2004
- Distributing ResponsibilitiesJournal of Political Philosophy, 2001
- Global Environment and International InequalityInternational Affairs, 1999